Cargando…
HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
SIMPLE SUMMARY: Pancreatic cancer progression involves interactions between cancer cells and stromal cells in harsh tumor microenvironments, which are characterized by hypoxia, few nutrients, and oxidative stress. Clinically, cancer cells overcome therapeutic interventions, such as chemotherapy and...
Autores principales: | Hamada, Shin, Matsumoto, Ryotaro, Masamune, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773475/ https://www.ncbi.nlm.nih.gov/pubmed/35053572 http://dx.doi.org/10.3390/cancers14020411 |
Ejemplares similares
-
Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition
por: Hamada, Shin, et al.
Publicado: (2021) -
Pancreatic Stellate Cells and Metabolic Alteration: Physiology and Pathophysiology
por: Hamada, Shin, et al.
Publicado: (2022) -
Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Cell Lines
por: Takikawa, Tetsuya, et al.
Publicado: (2022) -
Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer
por: Hamada, Shin, et al.
Publicado: (2013) -
Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction
por: Hamada, Shin, et al.
Publicado: (2013)